ArticleNature chemistry2026
Cyclophane-based shielding strategy for singly dispersed graphene nanoribbons.
Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Structurally precise graphene nanoribbons (GNRs) hold great promise for nanoelectronic devices owing to their tunable bandgaps and unique electronic properties. However, their practical integration into single-ribbon devices remains impeded by strong inter-ribbon aggregation. Here we introduce a cyclophane-based shielding strategy that not only sterically protects the GNR backbone but also imparts internal strain, enabling singly dispersed GNRs while simultaneously modulating their optoelectronic properties, as demonstrated by the synthesis and investigation of three cyclophane-shielded GNRs 1a-c and model nanographenes with varying cyclic chain lengths. Terahertz spectroscopy reveals a marked increase in short-range charge carrier mobility-from 190 to 330 cm
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.